ArticleFrontiers in bioengineering and biotechnology2022

Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy.

Chao-Gang Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.